Hikma Upgrades Full-Year Guidance For Generic And Branded Businesses
Injectables Sales Expected To Fall Within Lower End Of Existing Guidance Range
Hikma has provided a trading update in which it revised its expectations upwards for both its generic and branded business, while anticipating that its injectables unit will perform at the lower end of its current expectations.
